Drug Type Gene therapy |
Synonyms IKC 159V, IKC159V |
Target |
Mechanism CD46 modulators(Membrane cofactor protein modulators), PEDF modulators(Pigment epithelium-derived factor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Ikarovec Ltd.Startup |
Active Organization Ikarovec Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Geographic Atrophy | Preclinical | GB | Ikarovec Ltd.Startup | 23 Aug 2023 |